hydroxychloroquine has been researched along with ursodeoxycholic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Altiparmak, E; Efe, C; Karaaslan, Y; Muratori, P; Ozaslan, E; Ozbalkan, Z; Purnak, T; Wahlin, S | 1 |
| Chen, L; Chen, XZ; Wu, PB; Ye, HL; Zhang, G; Zhang, JW | 1 |
1 review(s) available for hydroxychloroquine and ursodeoxycholic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for hydroxychloroquine and ursodeoxycholic acid
| Article | Year |
|---|---|
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases.
Topics: Adult; Antibodies, Antinuclear; Azathioprine; Biopsy; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis, Autoimmune; Humans; Hydroxychloroquine; Immunoblotting; Immunoglobulin G; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Prevalence; Retrospective Studies; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2011 |
Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy.
Topics: Animals; Autophagy; Blotting, Western; Cell Line; Disease Models, Animal; Humans; Hydroxychloroquine; Hydroxyproline; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta1; Ursodeoxycholic Acid | 2020 |